Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VERAP TABLET 120MG 120MG TABLET Actual shortage 2024-03-13 2024-04-29 222116
APO-VERAP TABLET 120MG 120MG TABLET Actual shortage 2024-04-12 2024-04-26 225017
APO-VERAP TAB 80MG 80MG TABLET Resolved 2018-05-02 2018-07-12 47972
APO-VERAP TAB 80MG 80MG TABLET Resolved 2019-03-13 2019-04-05 78555
APO-VERAP TAB 80MG 80MG TABLET Resolved 2023-02-23 2023-03-02 185462
APO-VERAP TAB 80MG 80MG TABLET Resolved 2023-08-12 2023-09-29 201713
APO-VERAP TAB 80MG 80MG TABLET Resolved 2024-02-02 2024-04-19 218394
APO-VERAP SR 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 255
APO-VERAP SR 180MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 260
APO-VERAP SR 120MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-11 2019-12-04 552
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2017-07-25 2018-03-08 16886
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-09-27 2018-03-08 23658
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-03-08 69458
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-12-23 69460
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-18 2019-05-21 82022
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347

Showing 121 to 140 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TERAZOSIN 5MG TABLET Discontinued 2017-03-30 2018-02-05 4749
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40823
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40826
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40829
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40832
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-26 2018-02-26 40957
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40811
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40814
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-TAMOX TAB 20MG 20MG TABLET Discontinued 2018-09-10 2019-09-12 61050
APO-TADALAFIL 20MG TABLET Discontinued 2018-09-10 2019-02-13 61045
APO-SULIN TAB 200MG 200MG TABLET Discontinued 2017-03-13 2017-03-13 1172
APO-SULIN TAB 150MG 150mg tablet Discontinued 2017-03-13 2017-03-13 1186
APO-SUCRALFATE - TAB 1G 1G TABLET Discontinued 2018-09-10 2018-09-15 61033
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-SOTALOL 160MG TABLET Discontinued 2017-03-31 2018-02-05 4971
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269

Showing 41 to 60 of 356